Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nintedanib for Uterine Adhesions
NCT05635071Phase 3Unknown
- Sponsor
- The Sixth Affiliated Hospital of Sun Yat-Sen University
- Start
- Dec 2023
- Primary completion
- Jul 2024
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
01
Overview
A Phase 3 trial of nintedanib in Intrauterine Adhesions (IUA), sponsored by The Sixth Affiliated Hospital of Sun Yat-Sen University. Status: unknown.
02
Drugs
nintedanib
03
Conditions
Intrauterine Adhesions (IUA)
Beyond the preview
Go deeper on NCT05635071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05635071.